RJFSA
STML

Raymond James Financial Services Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History

Raymond James Financial Services Advisors’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,116
Closed -$189K – 2734
2017
Q4 		$189K Buy
+12,116
New +$189K ﹤0.01% 2281